Chemed CHE Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Chemed (CHE) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $4.55M in Q4 2025.
- How has Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value changed year-over-year?
- Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value decreased by 57.6% year-over-year, from $10.73M to $4.55M.
- What is the long-term trend for Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Over 4 years (2021 to 2025), Chemed's share based compensation arrangement by share based payment award options exercises in period total intrinsic value has grown at a -26.4% compound annual growth rate (CAGR), from $62.04M to $18.2M.
- What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
- The total intrinsic value realized by employees upon the exercise of stock options during the reporting period. This reflects the difference between the market price of the stock at the time of exercise and the exercise price, indicating the actual economic gain captured by participants.